A New Paradigm Shift in Antithrombotic Therapy

• Váldodahkkit: Anita ePudusseri (Dahkki), Raji eShameem (Dahkki), Alex eSpyropoulos (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2013-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Decades after the introduction of oral anti-coagulants namely the vitamin K antagonist Warfarin and antiplatelet agents such as Aspirin and Plavix, new classes of direct, small molecule, novel oral anti-coagulant medications and antiplatelet P2Y12 receptor inhibitors have recently become available....